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The endoplasmic reticulum (ER) is an organelle entrusted with lipid synthesis, calcium homeostasis, protein folding, and
maturation. Perturbation of ER-associated functions results in an evolutionarily conserved cell stress response, the unfolded
protein response (UPR) that is also called ER stress. ER stress is aimed initially at compensating for damage but can eventually
trigger cell death if ER stress is excessive or prolonged. Now the ER stress has been associated with numerous diseases. For
instance, our recent studies have demonstrated the important role of ER stress in diabetes-induced cardiac cell death. It is known
that apoptosis has been considered to play a critical role in diabetic cardiomyopathy. Therefore, this paper will summarize the
information from the literature and our own studies to focus on the pathological role of ER stress in the development of diabetic
cardiomyopathy. Improved understanding of the molecular mechanisms underlying UPR activation and ER-initiated apoptosis in
diabetic cardiomyopathy will provide us with new targets for drug discovery and therapeutic intervention.
1.Introduction
The endoplasmic reticulum (ER) is a central organelle
entrusted with lipid synthesis, calcium homeostasis, protein
folding, and maturation [1]. Most secreted and integral
membrane proteins of eukaryotic cells are translocated into
t h el u m e no fE R .T h eE Rl u m e np r o v i d e sas p e c i a l i z e d
environment for posttranslational modiﬁcation and folding
of secreted, transmembrane, and resident proteins of the
various compartments of the endomembrane system [2].
Various factors that interfere with ER function lead to
accumulation of unfolded proteins, including oxidative
stress, ischemia, disturbance of calcium homeostasis, and
overexpression of normal and/or incorrectly folded proteins.
This process is called ER stress and further activates the
unfolding protein response (UPR). There are two aims of the
UPR: the UPR initially tries to restore normal function of the
cellbyhaltingproteintranslationandactivatingthesignaling
pathways that lead to increasing the production of molecular
chaperones involved in protein folding; if these objectives are
not achieved within a certain time lapse or the disruption is
prolonged,theUPRtriestoturnonapoptoticpathway[3–6].
Therefore, the UPR can be considered as a safeguard for
protein synthesis, posttranslational modiﬁcations, folding
and secretion, calcium storage and signaling, and lipid bio-
synthesis [7–11]. Under normal conditions the ER main-
tains high concentrations of resident calcium-dependent
chaperone proteins, such as glucose-regulated protein-78
(GRP78, also known as BiP) and glucose-regulated protein-
94 (GRP94) [12], along with a high level of calcium and
an oxidized environment. Only properly folded proteins are
allowed to reach their ﬁnal destination, whereas unfolded
and misfolded proteins are exported or dislocated from the
ER and degraded by cytoplasmic proteasomes. The stresses
thatcancausetheUPRincludeavarietyofconditionssuchas
elevated secretory protein synthesis, overexpression and/or
accumulation of mutant proteins, aberrant Ca2+ regulation,
hypoxia,glucosedeprivation,alteredglycosylation,ischemia,
ER calcium depletion, viral infections, shifting of redox
statustoamorereducedstate,exposuretonaturalandexper-
imental toxins that perturb ER function, and overloading of
cholesterol [3, 10, 13–17].
Inhumanandanimalmodelsofdiabetes,aheartmuscle-
speciﬁcdiseaseintheabsenceofothervascularpathologyhas
been described, termed diabetic cardiomyopathy [18, 19].2 Experimental Diabetes Research
The pathogenesis of diabetic cardiomyopathy is a chronic
and complex process that is attributed to abnormal cellular
metabolism and defects in organelles such as myoﬁbrils,
mitochondria, and sarcolemma [20–24]. Probable candi-
dates to explain this heart disease include autonomic abnor-
malities, metabolic disorders, abnormal enzyme function,
and interstitial ﬁbrosis [25–27]. For instance, apoptosis, as
a regulated, energy-dependent, cell suicide mechanism has
also been reported to play a critical role in the development
of diabetic cardiomyopathy [28–31].
Recentlythe involvement of ER stress in the development
of diabetic cardiomyopathy was also reported [32, 33].
However, the mechanisms of diabetic cardiomyopathy are
not fully known, and appropriate approaches to minimize
these risks are still being explored. This paper focuses on
ER stress and its involvement in the development of diabetic
cardiomyopathy in order to provide certain new insights into
understanding of its mechanisms.
2. Adaptation to ERStress: Mechanisms to
Restore Homeostasis
The ability to adapt to physiological levels of ER stress
is important to cells. The initial intent of the UPR is
adaptation and restoration of the normal ER function. When
unfolded proteins accumulate in the ER, resident chaperones
become occupied, releasing transmembrane ER proteins
involved in inducing the UPR. These proteins straddle ER
membranes, with their N-terminus in the lumen of the ER
and their C-terminus in the cytosol, providing a bridge
that connects these 2 compartments. The N-termini of
thesetransmembraneERproteinsareusuallyassociatedwith
or bound to intralumenal GRP78 in the absence of ER
stress, preventing their aggregation. In some physiological or
pathologicalconditions, thelargeexcessofunfoldedproteins
in the ER lumen necessitates GRP78 dissociation and
launches the UPR. The UPR initially activates intracellular
signaling pathways mediated by three ER-resident proteins
in mammalian cells: the inositol-requiring kinase-1 (IRE-1)
[34, 35], the activating transcription factor 6 (ATF6), and the
protein kinase R-like ER kinase (PERK) [36, 37].
2.1. PERK. The UPR induces an early and transient attenu-
ation of protein biosynthesis which is mediated by PERK, an
ER-resident protein whose eﬀector the eukaryotic initiation
factor 2α kinase (eIF2α) domain lies on the cytoplasmic side
of the ER membrane and whose stress-sensing domain lies
on the opposite side of the membrane in the ER lumen
[38], as illustrated in Figure 1. The luminal domain of
monomeric PERK binds with the ER chaperone GRP78 in
an inactive complex under unstressed conditions. However,
as client proteins accumulate in the ER lumen, in eﬀorts
to assist folding, GRP78 relocates from PERK to misfolded
ER proteins. GRP78 relocalization allows PERK to dimerize,
which facilitates transautophosphorylation [39, 40]. PERK
is then activated, and it phosphorylates α-subunit of eIF2α
on serine-51. This phosphorylation event decreases cap- or
eIF2α-dependent translation, which shuts oﬀ global mRNA
translation and reduces the protein load on the ER [37, 39].
Global translational inhibition acutely reduces the protein-
folding load on the ER and allows the cell to focus resources
onresolvingtheERstress,thusfacilitatingsurvival.However,
certain mRNAs encoded by ER stress response (ERSR)
genes gains structural features and a selective advantage
for translation that allow them to escape PERK-mediated
translational inhibition [41]. For example, eIF2α phospho-
rylation induces expression of GRP78 and ATF4 under stress
[42, 43]. During the prosurvival phase of ER stress, ATF4
induces numerous genes involved in resolution of the ER
stress, such as genes that encode amino acid transporters
and ER-resident chaperones [43]. However, after prolonged
ER stress, continued ATF4 expression mediates the upreg-
ulation of genes that contribute to programmed cell death
(Figure 1).
2.2. IRE-1. Chaperone induction and ER-associated degra-
dation (ERAD), in response to ER stress, are regulated by the
IRE-1pathway.IRE-1containsbothaSer/Thrkinasedomain
and an endoribonuclease domain, which thus functions
as a kinase and an endoribonuclease. Like PERK, under
normal conditions, the luminal domain of IRE-1 monomers
associates with GRP78. Also in comparison with PERK,
during the prosurvival phase of the ERSR, GRP78 relocates
to misfolded proteins, which allows IRE-1 to dimerize,
thus facilitating transautophosphorylation [44]. However, in
contrast to PERK, transautophosphorylation of IRE-1 acti-
vates a novel endoribonuclease activity [45]. In mammalian
cells, the substrate for the IRE-1 endoribonuclease is the
X-box-binding protein-1 (XBP1) mRNA. After activation,
the IRE-1 endoribonuclease splices the XBP1 mRNA with
an altered reading frame. This XBP1 splice variant binds
to the promoters containing ER stress response elements
(ERSEs) [46]. These ﬁndings suggest that ER stress, acting
through the IRE-1- and XBP1-dependent signaling pathway,
upregulates the secretory apparatus in cells. Defective signal-
ing in this pathway would aﬀect professional secretory cells
(Figure 1).
2.3. ATF6. ATF6 is an ER transmembrane protein [47, 48].
Two similar transcription factors, ATF6α and ATF6β,e x i s t
in mammals. In comparison to PERK and IRE-1, in normal
cells, the luminal domain of ATF6 is associated with GRP78
inaninactiveform.Itshouldbementionedthateventhough
ERstressreleasesGRP78fromATF6,incontrasttoPERKand
IRE-1, this is not thought to be attributable to competitive
binding of GRP78 to other proteins [49]. Moreover, ATF6
exists in the ER as a dimer linked by intermolecular
disulﬁde bonds in the luminal domain. GRP78 dissociation
and disulﬁde bond cleavage on ER stress facilitate the
translocation of ATF6 to the Golgi [50], where it undergoes
cleavage by site-1 and site-2 proteases. This yields N-ATF6
that translocates to the nucleus and induces target ER genes
[36,48,51–58].Therefore,activationofATF6,IRE-1,andthe
downstream XBP1 (IRE-1-XBP1) increases the expression of
ER-resident chaperones. The genes induced by ATF6 during
the prosurvival phase of ER stress foster resolution of the
stressand,thus,survival,whereasthosegenesinducedontheExperimental Diabetes Research 3
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Figure 1: ER stress signaling pathways.
p r o a p o p t o t i cp h a s eo fE Rs t r e s sc o n t r i b u t et op r o g r a m m e d
cell death [59]( Figure 1).
2.4. Apoptosis Induced by ER Stress. The UPR deals with
adverse eﬀects of ER stress in a timely and eﬃcient manner
at the early stage and thus enhances cell survival. However,
when protein misfolding is persistent or excessive, prolonged
ER stress has severe consequences, including apoptosis.
When severe and prolonged ER stress extensively impairs the
ER functions, apoptosis is necessary not only for removing
the cells that threaten the integrity of the organism but also
forproperdevelopmentanddiﬀerentiation[1].Althoughthe
inductionofapoptosisistheleastwellunderstoodamongthe
responses to ER stress, the apoptotic mechanisms induced
by ER stress remain able to be broadly divided into a few
categories, as summarized in Figure 2.
The ﬁrst apoptotic pathway involves activation of the
c-Jun N-terminal kinase (JNK) pathway. During ER stress,
activated IRE-1 recruits tumor necrosis factor receptor-
associated factor 2 (TRAF2) and apoptosis signal-regulating
kinase 1 (ASK-1) to form IRE-1-TRAF2-ASK1 complex
w h i c ht h e nl e a dt oa c t i v a t i o no fJ N Ka n dd o w n s t r e a m
mitochondria/Apaf-1-dependent caspase activation [60, 61].
Also, the c-Jun-N-terminal inhibitory kinase (JIK) interacts
with activated IRE-1 and promotes phosphorylation and
association of TRAF2 with IRE-1 (Figure 2).
The second apoptotic pathway depends on the activation
of ER-localized cysteine protease, caspase-12 in rodents [62].
Several processes have been suggested as contributing factors
to caspase-12 activation in ER-stressed cells. m-Calpain, a
cysteine protease activated by disturbed calcium homeostasis
in ER-stressed cells, may directly cleave and activate caspase-
12 [63]. Caspase-7, which is translocated from cytosol to
the ER surface in stressed cells, can cleave and activate
caspase-12 [64]. ER stress-activated IRE-1 and PERK may
lead to clustering caspase-12 at the ER membranes by
recruitment of TRAF2 proteins [60]. Upon activation, in
rodents but not in humans, caspase-12 translocates from
the ER to the cytosol, where it directly cleaves procaspase-
9, which, in turn, activates the downstream eﬀector caspase,
caspase-3 without the need for mitochondrial ampliﬁcation
[62, 65]. Therefore, caspase-12-mediated apoptosis was a
speciﬁc apoptosis pathway of ER, which is independent
on mitochondria or death receptor activation. Caspase-
4, one of the closest paralogs of rodent caspase-12, has
been suggested to fulﬁll this role normally ascribed to
rodent caspase-12 in the context of ER stress in human
[66]( Figure 2). In a recent study, the enhanced expression
of the cleaved caspase-12 as an indicator of ER stress-
associated apoptosis was also observed in the diabetic heart
[32].
The third apoptotic pathway activated by ER stress is
mediated by transcriptional activation of CHOP/GADD153,
a member of the C/EBP family of b-ZIP transcription fac-
tor that potentiates apoptosis, possibly through repressing
expression of antiapoptotic Bcl2 and Bcl-XL and induc-
tion of ER oxidase 1α which generates reactive oxygen
species (ROS) and depletes glutathione (GSH) [67]. While
CHOP is barely detected under physiological conditions,4 Experimental Diabetes Research
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Figure 2: Apoptosis mechanisms induced by ER stress.
it is strongly induced in response to ER stress [68].
Although both the IRE-1 and ATF6 pathways can upreg-
ulate CHOP, the PERK pathway predominates through
selective upregulation of translation of ATF4, which sub-
sequently induces transcription of CHOP and other genes
involved in amino acid metabolism and transport, and
oxidation-reduction reactions [69, 70]. The downstream
targets of CHOP leading to apoptosis are still unclear
(Figure 2).
In addition, prolonged ER stress is associated with
r e l e a s eo fE RC a 2+ stores which can perturb mitochondria,
triggering oxidative stress. Ca2+-induced oxidative stress
can induce cell death. Increased cytosol Ca2+ also activates
calpains, a family of Ca2+-dependent cysteine proteases
which proteolytically cleave caspase-12 (activated), Bcl2, and
Bcl-XL (inhibited). Apoptosis is rapidly initiated after ER-
Ca2+ depletioninphotodynamictherapyandstrictlyrequires
Bax/Bak at the mitochondria [71]( Figure 2).
3. ERStress inthe Heart
3.1. Requirement of the ER Stress for the Heart. Several
studies have indicated that the ER stress is required for
the proper cardiac diﬀerentiation and development. It is
reported that many genes encoding ER-resident proteins
are activated during the early stages of cardiogenesis. For
instance, GRP78 can be activated to promote early heart
organogenesis through cooperation between the cell type-
speciﬁc transcription factors and ERSE-binding factors
[72]. GRP78 deﬁciency is lethal at a very early stage of
embryogenesis [73]. GRP94 knockout cells fail to develop
mesoderm, resulting in a prevention of cardiac development
from beginning [74]. Targeted disruption of the XBP1 gene
in mice is embryonic lethal because of cardiac development
defects[75].Allthesestudiesclearlyconﬁrmtherequirement
of ERSR for the proper cardiac development.
ERSR also involves in the cardiac protection against
certain challenges. For instance, GRP78 antisense oligo-
deoxynucleotide partially abrogated the protective eﬀect
of endothelin-1 pretreatment on hypoxic cardiomyocyte
injury [76]. Overexpression or pharmacological induction of
GRP78 can attenuate cardiomyocyte death induced by pro-
teasome inhibition [77]. Similarly, overexpression of GRP94
also reduces cardiac cell death caused by calcium overload
or ischemia [78]. In cardiac ischemia/reperfusion injuries
model, ATF6 transgenic hearts exhibited a better recovery of
ventricular pressure and lower incidence of cardiac cell death
[79]. A recent study showed that induction of autophagy
by ER stress before ischemia (similar to ischemic precon-
ditioning) could reduce ischemia/reperfusion-induced lethal
injury [80]. Therefore, the ER stress is not only required for
the cardiac development, but also provide certain protective
mechanisms for the heart against damage caused by various
stresses.Experimental Diabetes Research 5
3.2. The Deleterious Eﬀect of the ER Stress on the Heart. How-
ever, ER stress is demonstrated to be pathologically involved
incardiacdiseasesanddamagesundernumerousconditions,
including myocardial infarction, ischemia/reperfusion, and
pressure overload. For example, the ERSR is activated in
the hearts of transgenic mice that overexpress monocyte
chemoattractant protein-1 (MCP-1) and develop heart fail-
ure [81]. They found that the heart failure is mainly due
to the activated proapoptotic phase of ERSR that led to
massive loss of cardiomyocytes [81]. A further support of
a role for ER stress in heart failure is the ﬁnding that
transgenic overexpression of a mutant KDEL receptor, a re-
trieval receptor for ER chaperones in the early secretory
pathway, induced the ERSR in the hearts, in parallel with a
consequence of dilated cardiomyopathy [82].
Hypoxia is an insult that activates cardiac ER stress. Dur-
ing ischemia that could result from the reduced availability
of molecular oxygen, signiﬁcant changes in cardiac energy
metabolism happen [83]. Under severe hypoxia, anaerobic
metabolism has to occur and results in a massive increase
in ROS, leading to cardiac oxidative damage, cell death, and,
ultimately, cardiac dysfunction [84]. In addition, reperfusion
after ischemia generates increased oxidative stress as the
heartconvertsbacktoaerobicrespiration,therebygenerating
lethal levels of ROS. Ischemia/reperfusion injury in the heart
resultsinnumerouscellularandmoleculareventsthatleadto
loss of cardiac damage and dysfunction, such as disrupting
ER oxidative state or Ca2+ homeostasis, triggering cellular
damage, and eventually causing cardiac apoptotic death
[84, 85].
Apoptotic cell death as an early cellular event in response
to diabetes has been reported to play a critical role in the
development of diabetic cardiomyopathy [28–30]. Because
myocytes rarely proliferate in adult cardiac muscles, the loss
of cardiomyocytes would eventually lead to compromised
cardiac function. Loss of endothelial cells will lead the
vascular system to dysfunction and aggravate the ischemia
of the heart. Apoptosis of cardiomyocytes and endothelial
cells has been observed in the heart of patient with diabetes
and in streptozotocin- (STZ-) induced diabetic mice and
rats [27, 29, 86]. Pieces of evidence have demonstrated that
apoptosis induced by ER stress was involved in pathogenesis
of diabetic and nondiabetic heart failure [87–89]. UPR
and ER-initiated apoptosis coexist in failing hearts and the
CHOP-dependent cell death pathway may be involved in the
transition from cardiac hypertrophy to heart failure in mice
[90]. Recent studies have also demonstrated the UPR and
activation of ER-initiated apoptotic signaling in models of
autoimmune cardiomyopathy [91] and alcoholic cardiomy-
opathy [92]. Overexpression of the ERSR gene product, p53-
upregulated modulator of apoptosis (PUMA), contributes
to ER stress-mediated apoptosis in cultured cardiomyocytes
[93] and targeted deletion of PUMA in mouse hearts at-
tenuates cardiomyocyte death during Langendorﬀ ex vivo
ischemia/reperfusion [94]. All these studies demonstrated
that apoptotic death of cardiac cells plays a critical role of
the development of diabetic cardiomyopathy, whether the
cardiac cell death at diabetic early stage is mediated by
diabetic induction of the ER stress still needs to be further
studied.
4. Contribution of the ER Stress to
DiabeticCardiomyopathy
As early as 1985, whether the ER stress may play an impor-
tant role in the development of diabetic cardiomyopathy
has been questioned since in the diabetic hearts the ERs
become swollen under ultrastructural examination [95, 96],
suggesting the disorder of the ER under diabetic condition.
In 2007, Li et al. provided the experimental evidence for the
involvement of the ER stress in the cardiac apoptosis in a
STZ-induced type 1 diabetic rat model [32]. They examined
the heart function with echocardiography, morphological
changes with hematoxylin-eosin staining, and cardiac cell
death with TUNEL staining. Immunohistochemistry, West-
ern blot, and real-time PCR methods were used to examine
two ER stress hallmarks, GRP78 and caspase-12. They
found that GRP78 and caspase-12 were upregulated at both
protein and mRNA levels in the diabetic hearts compared to
normal hearts. Since apoptosis plays critical role in diabetic
cardiomyopathy [28, 30], those results suggested that the
ER stress was induced in the diabetic hearts, and the ER
stress-associated apoptosis took part in the pathogenesis of
diabetic cardiomyopathy. We have also demonstrated the
cardiac up-regulation of several ERSR proteins, including
PERK- and ATF6-mediated pathways in diabetic hearts of
mice model induced by multiple low doses of STZ (MLD-
STZ).However,theseERSRwerenotobservedinthediabetic
mice with cardiac-speciﬁc overexpression of metallothionein
(MT) gene (MT-TG) [86] .S i n c ew eh a v ed e m o n s t r a t e d
that diabetes-induced cardiac cell death was prevented by
MT at the diabetic early stage, resulting in a signiﬁcant
prevention of cardiac remodeling and dysfunction at the 5
or 6 months, that is, a signiﬁcant prevention of diabetic
cardiomyopathy. Based on that study we further assumed
that MT prevented diabetic cardiomyopathy via suppression
of diabetic induction of ER stress and associated cell death.
To deﬁne the direct protection by MT from ER stress-
mediated apoptotic cell death, both MT-TG mice and the
age-matched wild-type (WT) mice were administrated with
chemical ER stress inducer, tunicamycin. We found that
cardiac ERSR such as p-eIF2, cleaved ATF6 and GRP78
and cardiac cell death all were signiﬁcantly upregulated
in tunicamycin-treated WT mice, but not in tunicamycin-
treated MT-TG mice [86].
We have approved that Ang II plays a critical role in
the development of diabetic cardiomyopathy [97]; therefore,
we have explored and demonstrated that the exposure of
embryonic rat heart-derived cells (H9c2) to induced a sig-
niﬁcant ERSR, eﬀect abolished by MT in Ang II-treated MT-
TG mice [86]. The direct role of Ang II in the induction of
cardiac ERSR was also approved by a recent study that olme-
sartan treatment downregulated the cardiac expressions of
GRP78 and caspase-12, along with oxidative and nitrosative
damage [98]. To support this study, Wu et al. reported that
valsartan, another selective AT1 receptor antagonist, could
relieve the ER stress along with cardiomyocyte apoptosis,6 Experimental Diabetes Research
resulting in a signiﬁcant prevention of cardiac remodeling
[99].
It is well appreciated now that in addition to hyper-
glycemia and Ang II, diabetic heart experiences many other
conditions that can invoke ER stress, such as increased
oxidative stress, hypoxia, homocysteine, lipid deposition,
and increased synthesis of secretory proteins [100–102].
A recent study reported the role of homocystein- (Hcy-)
induced ER stress in diabetic cardiomyopathy [103]. Since
signiﬁcant increase in Hcy has been indicated in the devel-
opment of diabetic cardiomyopathy, whether its pathogenic
eﬀect on diabetic heart is also related to ER stress has been
addressed using a rat model of Hcy. These rats were given
overloaded methionine to induce high-plasma Hcy. In the
heart of these rats, there were signiﬁcant increases in GRP78,
CHOP, and caspase-12, suggesting the existence of cardiac
ER stress induced by Hcy that also plays a critical role in the
development of diabetic cardiomyopathy [103].
5.PotentialMechanismsby Whichthe
ERStress Causesthe Development of
DiabeticCardiomyopathy
The molecular mechanisms by which hyperglycemia causes
cell death are probably related to ROS production. ROS
is mainly produced by mitochondria and NADPH oxidase
in cardiomyocytes [29, 104]. We have used MT transgenic
model to indicate the importance of oxidative stress in the
induction of ER stress in the diabetic heart. Since MT is a
potent, nonspeciﬁc antioxidant that can scavenge multiple
ROS and/or RNS [104–106], we have examined whether
diabetes induces cardiac ER stress and, if so, whether MT
can prevent diabetic induction of the ER stress, resulting in
a prevention of cardiomyopathy as we observed in previous
studies [30, 107, 108]. Therefore we used STZ to induce dia-
betes in both MT-TG and WT mice. Two weeks, and 2 and 5
monthsafterdiabetesonset,cardiacERstresswasdetectedby
expression of ER chaperones, and apoptosis was detected by
CHOP, cleaved caspase-3 and caspase-12. Cardiac apoptosis
in the WT diabetic mice, but not in MT-TG diabetic mice,
was signiﬁcantly increased 2 weeks after diabetes onset [86].
In parallel with apoptotic eﬀect, signiﬁcant up-regulation
of the ER chaperones, including GRP78, GRP94, cleaved
ATF6 and phosphorylated eIF2α, in the hearts of WT, but
not MT-TG diabetic mice. Pretreatment with antioxidants
completelypreventedAngII-inducedERstressandapoptosis
in the cultured cardiac cells. Therefore, our results suggested
that ER stress exists in the diabetic heart, which may cause
the cardiac cell death. MT prevents both diabetes-induced
cardiac ER stress and associated cell death most likely via
its antioxidant action, which may be responsible for MT
prevention of diabetic cardiomyopathy [86].
In consistence with our ﬁnding, recently, Younce et al.
[109] also reported that high glucose induces cardiomyocyte
death via production of MCP-1 and induction of MCP-1-
induced protein (MCPIP) that results in ROS production,
leading to ER stress to cause autophagy and eventual cell
death. Selective inhibition of Rac1 or NADPH oxidase
prevents ER stress by blocking ROS production in high-
glucose-stimulated cardiomyocytes [110].
Diabetes may impair ERSR so that certain functions
that can be observed in nondiabetic condition may not be
observed in diabetic condition. For instance, under nondi-
abetic condition, pretreatment with erythropoietin (EPO)
can prevent ischemia/reperfusion-induced cardiac damage,
but the ER stress in diabetic hearts abolished EPO-induced
cardiac protection by impairment of phospho-glycogen
synthase kinase-3β-( G S K - 3 β-) mediated suppression of
mitochondrial permeability transition [111]. In this study,
the authors used type 2 diabetic (OLETF) rats and its
control (LETO) to be treated with tauroursodeoxycholic
acid (TUDCA) to induce ER stress. Infarction was induced
by 20min coronary occlusion and 2h reperfusion. Levels
of ER chaperones (GRP78 and GRP94) in the heart and
level of non-phoshopho-GSK-3β in the mitochondria were
signiﬁcantly higher in OLETF than in LETO rats. TUDCA
normalized levels of GRP78 and GRP94 and mitochondrial
GSK-3β in OLETF rats. Administration of EPO induced
phosphorylation of Akt and GSK-3β and reduced infarct size
in LETO hearts. However, neither phosphorylation of Akt
and GSK-3β nor infarct size limitation was induced by EPO
inOLETFrats.Thethresholdformitochondrialpermeability
transition pore (mPTP) opening was signiﬁcantly lower
in mitochondria from EPO-treated OLETF rats than in
those from EPO-treated LETO rats. Therefore, disruption
of protective signals leading to GSK-3β phosphorylation
is due to the increased ER stress that inhibited EPO-in-
duced suppression of mPTP opening and cardioprotection
in diabetic hearts [111].
There was a recent study that has addressed how glucose
induces ER stress in cardiac cells [109]. They found that
glucose-induced cardiomyocyte death is mediated via MCP-
1 production and MCPIP, which causes sequential events—
ROS production, ER stress, autophagy, and cell death [109].
This is an elegant study, in which H9c2 cardiomyoblasts
treated with 28mmol/L glucose were evaluated for MCP-1
production and induction of MCPIP. They disrupted MCP-
1 to interact with its receptor, CCR2, and knocked down
MCPIP with siRNA to determine if MCP-1 and MCPIP
mediate glucose-induced cell death glucose treatment of
H9c2 cardiomyoblasts and isolated cardiomyocytes caused
MCP-1 production, MCPIP induction, ROS production, ER
stress, autophagy, and cell death. Treatment with CCR2
antagonists and knockdown of MCPIP attenuated glucose-
induced ROS production, ER stress, autophagy, and cell
death. Inhibition of ROS with antioxidants attenuated ER
stress, autophagy, and cell death. Speciﬁc inhibitors of ER
stress and knockdown of IRE-1 attenuated glucose-induced
autophagy and cell death. Inhibitors of autophagy and
knockdown of beclin-1 attenuated glucose-induced death.
Therefore, they have demonstrated a novel mechanism:
hyperglycemia-induced cardiomyocyte ER stress and cell
death are mediated via MCP-1 production and induction of
a novel zinc-ﬁnger protein MCPIP [109].
In summary, various pathogenic factors of diabetes
most likely induce ROS that in turns causes the ER
stress and associated cell death, as illustrated in Figure 3.Experimental Diabetes Research 7
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Figure 3: Outlining the involvement of ER stress in the develop-
ment of diabetic cardiomyopathy.
Cardiac cell death will initiate the cardiac inﬂammation
and remodeling and eventually cardiac dysfunction, that is,
diabetic cardiomyopathy. The pathogenic factors of diabetes
includehyperglycemia,hyperlipidemia,andAngIIandsoon
(Figure 3).
6. PotentialPreventionof Diabetic
Cardiomyopathy by Inhibition of ER Stress
Since the above studies have strongly demonstrated the
critical role of ER stress in the development of diabetic
cardiomyopathy, ER stress inhibitors would be the new
targets for drug discovery and therapeutic intervention
in diabetic cardiomyopathy. Chemical or pharmaceutical
chaperones, such as 4-phenyl butyric acid (PBA), TUDCA
are a group of low-molecular-weight compounds known
to stabilize protein conformation to improve ER folding
capacity and facilitate the traﬃcking of mutant proteins.
Studies have shown that these chemical ER chaperones can
reduce ER stress in a mouse model of type 2 diabetes
[112]. TUDCA normalized levels of GRP78 and GRP94
and mitochondrial GSK-3β in the rat model of type 2
diabetes [111]. Inhibition of ER stress with tauroursodeoxy-
cholate (TUDC) and PBA resulted in the attenuation of
cardiomyoblast death [109]. Our recent studies have shown
cardiac overexpression of MT rescued diabetes-, Ang II-,
and even chemical ER stressor-induced cardiac cell death
via suppression of cardiac ER stress. MT protection against
Ang II-induced ER stress and associated apoptotic eﬀects are
mediated by its antioxidant action; this suggests that MT
inducers such as zinc may also play the same role as the ER
stress direct inhibitors [109, 112]. We have treated diabetic
mice for the ﬁrst three months after the establishment
of STZ-induced hyperglycemia, resulting in a signiﬁcant
prevention of the development of diabetic cardiomyopathy
[113]. Although we did not examine the status of ER stress in
the heart for that study, zinc treatment signiﬁcantly induced
cardiac MT expression that might prevent diabetic induction
of the ER stress and associated cell death as we observed in
other studies [86].
There were also some studies to indirectly inhibit ER
stress for the prevention of diabetic cardiomyopathy. Wu et
al. have explored the possibility to use valsartan to prevent
diabetic ER stress and consequently prevented diabetic car-
diomyopathy [99]. They demonstrated that valsartan can
ameliorate ER stress-induced cardiac remodeling and myo-
cardial apoptosis in diabetic cardiomyopathy. Similarly,
hydrogen sulﬁde was also explored for the potential to
attenuate hyperhomocysteinemia-induced cardiomyocytic
ERstressintheratmodel[103],withaﬁndingthathydrogen
sulﬁde attenuated cardiomyocyte ER stress in Hcy-induced
cardiac injury.
14-3-3 protein was also found to protect against cardiac
ER stress and ER stress-initiated apoptosis in experimental
diabetes [114]. STZ was used to induce transgenic mice
that showed cardiac-speciﬁc expression of a dominant
negative (DN) 14-3-3eta protein mutant. The expression
levels of cardiac GRP78, IRE-1α, and TRAF 2 protein were
signiﬁcantly increased in the diabetic DN 14-3-3eta mice
compared with the diabetic wild-type control. Moreover,
cardiac apoptosis and the expression of CHOP, caspase-12,
and cleaved caspase-12 protein were signiﬁcantly increased
in the diabetic DN 14-3-3eta mice. Therefore, they found
that partial depletion of 14-3-3 protein in the diabetic heart
exacerbates cardiac ER stress and activates ER stress-induced
apoptosis pathways, at least in part, through the regulation
of CHOP and caspase-12 via the IRE-1α/TRAF2 pathway.
The enhancement of 14-3-3 protein expression can be used
as a novel protective therapy against ER stress and ER stress-
initiated apoptosis in the diabetic heart [114].
It is reported that low levels of adiponectin, a fat-
derived hormone, were found to be correlated with coronary
heart disease, type 2 diabetes, obesity, and insulin resis-
tance. Conversely, high adiponectin levels are predictive of
reduced coronary risk in long-term epidemiologic studies.
Whether adiponectin has certain cardiac protection and, if
so, whether the cardiac protection of adiponectin is related
to ER stress have been questioned by Dong and Ren [115].
They have examined the role of adiponectin in cardiac
contractile function in the db/db model of diabetic obesity
anddemonstratedthatadiponectinimprovedcardiomyocyte
contractile function in db/db diabetic obese mice, which was
notassociatedwithimprovementoftheERstress[115].They
demonstrated that cardiomyocytes from db/db mice exhib-
ited greater cross-sectional area, depressed peak shortening,
and maximal velocity of shortening/relengthening as well as
prolonged duration of relengthening. Consistently, myocytes
from db/db mice displayed a reduced electrically stimulated
rise in intracellular Ca2+ and prolonged intracellular Ca2+
decay. These functional and Ca2+ changes were abrogated
by adiponectin treatment. Levels of the phosphorylated ER8 Experimental Diabetes Research
stress makers PERK (Thr980), IRE-1, and eIF2α were signif-
icantly elevated in db/db mice compared with lean controls,
but the eﬀect was unaﬀected by adiponectin. Collectively,
they concluded that adiponectin improves cardiomyocyte
dysfunction in db/db diabetic obese mice through an ER
stress-independent mechanism. However, this study was
in contrast to another study that showed that TUDCA
normalized levels of GRP78 and GRP94 and mitochondrial
GSK-3β in the rat model of type 2 diabetes resulted in
signiﬁcant prevention of diabetic cardiac damage [111].
Therefore more studies with diﬀerent types of diabetes and
diﬀerentconditionsareneededtoaddresswhetherinhibition
of ER stress can prevent diabetic cardiomyopathy in T2D
model.
As illustrated in Figure 3, these studies have indicated the
potential application of various direct and indirect ER stress
inhibitors to prevent diabetic ER stress-mediated cell death,
and eventually the development of the cardiac remodeling
and dysfunction, as a potential approach applied clinically in
the future.
7. Conclusions
In conclusion, although our understanding of the patho-
physiological role of ER stress in diabetic cardiomyopathy
hasprogressedinrecentyears,manyimportantissuesarestill
unresolved. There are several fundamental questions. One of
theseimportantissuesishowthecelldecidesbetweenlifeand
deathaftertheonsetofERstress.Improvedunderstandingof
the molecular mechanisms underlying UPR activation and
ER-initiated apoptosis in diabetic cardiomyopathy will pro-
vide us with new targets for drug discovery and therapeutic
intervention.
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